IBDEI2J1 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,42863,0)
 ;;=N47.8^^162^2048^17
 ;;^UTILITY(U,$J,358.3,42863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42863,1,3,0)
 ;;=3^Prepuce disorders,other
 ;;^UTILITY(U,$J,358.3,42863,1,4,0)
 ;;=4^N47.8
 ;;^UTILITY(U,$J,358.3,42863,2)
 ;;=^5015730
 ;;^UTILITY(U,$J,358.3,42864,0)
 ;;=N47.7^^162^2048^18
 ;;^UTILITY(U,$J,358.3,42864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42864,1,3,0)
 ;;=3^Prepuce inflammatory diseases,Other
 ;;^UTILITY(U,$J,358.3,42864,1,4,0)
 ;;=4^N47.7
 ;;^UTILITY(U,$J,358.3,42864,2)
 ;;=^5015729
 ;;^UTILITY(U,$J,358.3,42865,0)
 ;;=N48.1^^162^2048^2
 ;;^UTILITY(U,$J,358.3,42865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42865,1,3,0)
 ;;=3^Balanitis
 ;;^UTILITY(U,$J,358.3,42865,1,4,0)
 ;;=4^N48.1
 ;;^UTILITY(U,$J,358.3,42865,2)
 ;;=^12525
 ;;^UTILITY(U,$J,358.3,42866,0)
 ;;=N47.6^^162^2048^3
 ;;^UTILITY(U,$J,358.3,42866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42866,1,3,0)
 ;;=3^Balanoposthitis
 ;;^UTILITY(U,$J,358.3,42866,1,4,0)
 ;;=4^N47.6
 ;;^UTILITY(U,$J,358.3,42866,2)
 ;;=^12530
 ;;^UTILITY(U,$J,358.3,42867,0)
 ;;=N48.30^^162^2048^21
 ;;^UTILITY(U,$J,358.3,42867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42867,1,3,0)
 ;;=3^Priapism, Unspec
 ;;^UTILITY(U,$J,358.3,42867,1,4,0)
 ;;=4^N48.30
 ;;^UTILITY(U,$J,358.3,42867,2)
 ;;=^5015733
 ;;^UTILITY(U,$J,358.3,42868,0)
 ;;=N48.32^^162^2048^19
 ;;^UTILITY(U,$J,358.3,42868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42868,1,3,0)
 ;;=3^Priapism d/t disease classified elsewhere
 ;;^UTILITY(U,$J,358.3,42868,1,4,0)
 ;;=4^N48.32
 ;;^UTILITY(U,$J,358.3,42868,2)
 ;;=^5015735
 ;;^UTILITY(U,$J,358.3,42869,0)
 ;;=N48.33^^162^2048^22
 ;;^UTILITY(U,$J,358.3,42869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42869,1,3,0)
 ;;=3^Priapism, drug-induced
 ;;^UTILITY(U,$J,358.3,42869,1,4,0)
 ;;=4^N48.33
 ;;^UTILITY(U,$J,358.3,42869,2)
 ;;=^5015736
 ;;^UTILITY(U,$J,358.3,42870,0)
 ;;=N48.39^^162^2048^20
 ;;^UTILITY(U,$J,358.3,42870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42870,1,3,0)
 ;;=3^Priapism, Other
 ;;^UTILITY(U,$J,358.3,42870,1,4,0)
 ;;=4^N48.39
 ;;^UTILITY(U,$J,358.3,42870,2)
 ;;=^5015737
 ;;^UTILITY(U,$J,358.3,42871,0)
 ;;=N50.1^^162^2048^24
 ;;^UTILITY(U,$J,358.3,42871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42871,1,3,0)
 ;;=3^Vascular disorders male genital organs
 ;;^UTILITY(U,$J,358.3,42871,1,4,0)
 ;;=4^N50.1
 ;;^UTILITY(U,$J,358.3,42871,2)
 ;;=^125508
 ;;^UTILITY(U,$J,358.3,42872,0)
 ;;=N52.9^^162^2048^8
 ;;^UTILITY(U,$J,358.3,42872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42872,1,3,0)
 ;;=3^Male erectile dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,42872,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,42872,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,42873,0)
 ;;=N52.39^^162^2048^16
 ;;^UTILITY(U,$J,358.3,42873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42873,1,3,0)
 ;;=3^Post-surg erectile dysfunction,Other
 ;;^UTILITY(U,$J,358.3,42873,1,4,0)
 ;;=4^N52.39
 ;;^UTILITY(U,$J,358.3,42873,2)
 ;;=^5015761
 ;;^UTILITY(U,$J,358.3,42874,0)
 ;;=N53.9^^162^2048^10
 ;;^UTILITY(U,$J,358.3,42874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42874,1,3,0)
 ;;=3^Male sexual dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,42874,1,4,0)
 ;;=4^N53.9
 ;;^UTILITY(U,$J,358.3,42874,2)
 ;;=^5015769
 ;;^UTILITY(U,$J,358.3,42875,0)
 ;;=N53.12^^162^2048^12
 ;;^UTILITY(U,$J,358.3,42875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42875,1,3,0)
 ;;=3^Painful ejaculation
 ;;^UTILITY(U,$J,358.3,42875,1,4,0)
 ;;=4^N53.12
 ;;^UTILITY(U,$J,358.3,42875,2)
 ;;=^5015765
 ;;^UTILITY(U,$J,358.3,42876,0)
 ;;=N53.8^^162^2048^9
 ;;^UTILITY(U,$J,358.3,42876,1,0)
 ;;=^358.31IA^4^2
